Veronica Hoiom

Solna, AB 17164, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 55 publications

Mental- and physical health, and general well-being in patients with polyposis syndromes: a scoping review.

Mental- and physical health, and general well-being in patients with polyposis syndromes: a scoping review.

Journal: Familial cancer

Published: October 03, 2025

Evolutionary Origin of Ocular Melanoma: Associations With rs12913832 G Allele Frequency and Latitude.

Evolutionary Origin of Ocular Melanoma: Associations With rs12913832 G Allele Frequency and Latitude.

Journal: Cancer medicine

Published: August 27, 2025

POT1 genetic testing in melanoma-prone families in Sweden: germline variant prevalence and tumor spectrum in identified carriers.

POT1 genetic testing in melanoma-prone families in Sweden: germline variant prevalence and tumor spectrum in identified carriers.

Journal: Acta oncologica (Stockholm, Sweden)

Published: June 03, 2025

Germline MC1R Variant Status and Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Melanoma.

Germline MC1R Variant Status and Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Melanoma.

Journal: Pigment cell & melanoma research

Published: May 30, 2025

Familial features affecting the melanoma risk in CDKN2A-negative melanoma families: a study based on the Swedish Cancer Registry.

Familial features affecting the melanoma risk in CDKN2A-negative melanoma families: a study based on the Swedish Cancer Registry.

Journal: Acta oncologica (Stockholm, Sweden)

Published: October 06, 2023

BAP1 genetic testing among melanoma and cancer-prone families in Sweden.

BAP1 genetic testing among melanoma and cancer-prone families in Sweden.

Journal: Acta oncologica (Stockholm, Sweden)

Published: June 02, 2023

Gene-Level Associations in Patients With and Without Pathogenic Germline Variants in CDKN2A and Pancreatic Cancer.

Gene-Level Associations in Patients With and Without Pathogenic Germline Variants in CDKN2A and Pancreatic Cancer.

Journal: JCO precision oncology

Published: November 21, 2022

Proliferation and Immune Response Gene Signatures Associated with Clinical Outcome to Immunotherapy and Targeted Therapy in Metastatic Cutaneous Malignant Melanoma.

Proliferation and Immune Response Gene Signatures Associated with Clinical Outcome to Immunotherapy and Targeted Therapy in Metastatic Cutaneous Malignant Melanoma.

Journal: Cancers

Published: June 02, 2022

Whole-Exome Sequencing of Germline Variants in Non-BRCA Families with Hereditary Breast Cancer.

Whole-Exome Sequencing of Germline Variants in Non-BRCA Families with Hereditary Breast Cancer.

Journal: Biomedicines

Published: March 23, 2022

Plasma Thymidine Kinase Activity as a Novel Biomarker in Metastatic Melanoma Patients Treated with Immune Checkpoint Inhibitors.

Plasma Thymidine Kinase Activity as a Novel Biomarker in Metastatic Melanoma Patients Treated with Immune Checkpoint Inhibitors.

Journal: Cancers

Published: December 15, 2021

A biomarker panel predicts recurrence-free survival in ulcerated primary cutaneous melanoma.

A biomarker panel predicts recurrence-free survival in ulcerated primary cutaneous melanoma.

Journal: Acta oncologica (Stockholm, Sweden)

Published: October 25, 2021

Novel loss-of-function variant in DENND5A impedes melanosomal cargo transport and predisposes to familial cutaneous melanoma.

Novel loss-of-function variant in DENND5A impedes melanosomal cargo transport and predisposes to familial cutaneous melanoma.

Journal: Genetics in medicine : official journal of the American College of Medical Genetics

Published: May 05, 2021

Showing 1-12 of 55

Last Updated: 09/26/2026